| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences |  | | 2023 | 126 | 345 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 445 | 195 |
|
| Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment | Cancers | | | 2020 | 254 | 141 |
|
| Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance | Cancers | | | 2020 | 378 | 331 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules | | | 2020 | 386 | 351 |
|
| Challenges and considerations in designing multidrug combinations for cancer treatment | | | | 2020 | 711 | 357 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers | | | 2019 | 544 | 350 |
|
| Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma | Scientific Reports | | | 2019 | 450 | 280 |
|
| Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment | Angiogenesis | | | 2017 | 304 | 485 |
|
